Drug Shortage Report for TROMBOJECT 3%

Last updated on 2025-05-02 History
Report ID 206240
Drug Identification Number 00511226
Brand name TROMBOJECT 3%
Common or Proper name Sodium Tetradecyl Sulfate Injection
Company Name OMEGA LABORATORIES LIMITED
Market Status MARKETED
Active Ingredient(s) SODIUM TETRADECYL SULFATE
Strength(s) 30MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 10 x 2mL vial / fiole
ATC code C05BB
ATC description ANTIVARICOSE THERAPY
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2025-04-21
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2025-05-02
Company comments We are currently collaborating with Health Canada’s Drug Shortages Unit to mitigate any market impact.
Health Canada comments
Tier 3 Status No
Contact Address 11177 HAMON
MONTREAL, QUEBEC
CANADA H3M 3E4
Company contact information [email protected] - 1-800-363-0584

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v11 2025-05-02 French Compare
v10 2025-05-02 English Compare
v9 2025-05-02 French Compare
v8 2025-05-02 English Compare
v7 2025-04-22 English Compare
v6 2025-04-21 French Compare
v5 2025-04-21 English Compare
v4 2024-01-16 French Compare
v3 2024-01-16 English Compare
v2 2023-10-04 French Compare
v1 2023-10-04 English Compare

Showing 1 to 11 of 11